Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Choyke

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenibRonan J Kelly, Arun Rajan, Jeremy Force, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2013
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohortNilofer Azad, Minshu Yu, Ben Davidson, et al.
Molecular Imaging|October 14, 2015
Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [99mTc] (AH-113018) or Cy 5** (AH-112543) Labeled PeptideElaine M Jagoda, Sibaprasad Bhattacharyya, Joseph Kalen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Detection Efficacy of <sup>18</sup>F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyFrederik L Giesel, Karina Knorr, Fabian Spohn, et al.
The Journal of Pediatrics|June 23, 2009
MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert SyndromeMeral Gunay-Aygun, Melissa A Parisi, Dan Doherty, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|September 14, 2018
Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experienceKareem N Rayn, Graham R Hale, Jonathan B Bloom, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology ImagesSushant Patkar, Alex Chen, Alina Basnet, et al.
Brachytherapy|May 6, 2022
Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancerKilian E Salerno, Baris Turkbey, Liza Lindenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndromeBerton Zbar, W Gregory Alvord, Gladys Glenn, et al.
The Journal of Urology|June 1, 2018
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate CancerKareem N Rayn, Jonathan B Bloom, Samuel A Gold, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenibRonan J Kelly, Arun Rajan, Jeremy Force, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2013
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohortNilofer Azad, Minshu Yu, Ben Davidson, et al.
Molecular Imaging|October 14, 2015
Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [99mTc] (AH-113018) or Cy 5** (AH-112543) Labeled PeptideElaine M Jagoda, Sibaprasad Bhattacharyya, Joseph Kalen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Detection Efficacy of <sup>18</sup>F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyFrederik L Giesel, Karina Knorr, Fabian Spohn, et al.
The Journal of Pediatrics|June 23, 2009
MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert SyndromeMeral Gunay-Aygun, Melissa A Parisi, Dan Doherty, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|September 14, 2018
Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experienceKareem N Rayn, Graham R Hale, Jonathan B Bloom, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology ImagesSushant Patkar, Alex Chen, Alina Basnet, et al.
Brachytherapy|May 6, 2022
Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancerKilian E Salerno, Baris Turkbey, Liza Lindenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndromeBerton Zbar, W Gregory Alvord, Gladys Glenn, et al.
The Journal of Urology|June 1, 2018
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate CancerKareem N Rayn, Jonathan B Bloom, Samuel A Gold, et al.
Pageof 17